HealthDay News — COVID-19 vaccination, especially with a booster dose, is associated with reduced odds of preeclampsia (PE), according to a study published online February 18 in eClinicalMedicine.

Booster vaccines reduced the risk of COVID‑19–related hospitalization and death, according to a new study of over 3 million ...

For anyone terrified of needles, we have some good news for you – we’re one step closer to a one-size-fits-all vaccine for ...

Booster vaccines reduced the risk of COVID‑19-related hospitalization and death, according to a new study of over 3 million ...

Among women who never got sick, researchers found the shots appeared to improve vascular and immune health. For mothers with ...

A new multinational study from the INTERCOVID Consortium, including Ann & Robert H. Lurie Children's Hospital of Chicago, has ...

A global study found COVID-19 booster vaccination during pregnancy was associated with lower odds of preeclampsia, even among ...

COVID-19 vaccination reduces the risk of preeclampsia among pregnant women who have received a booster dose by 33%, a 2026 prospective cohort study has found. COVID-19 infection during pregnancy was ...

Emergency Care Reduction: The study of the 2024–2025 vaccine showed a 29.3% effectiveness (95% confidence interval [CI], 19.1 to 39.2) against Covid-19–related ED visits, preventing approximately 18.3 ...

By Hugo Francisco de Souza A novel nasal booster approach may help close the gap between systemic vaccination and infection-blocking mucosal immunity, offering fresh insight into next-generation COVID ...